(Sharecast News) - Danish drugs giant Novo Nordisk posted a jump in second-quarter profit on Wednesday, against a backdrop of reduced sales forecasts, potential US tariffs and competitors threatening its blockbuster Ozempic and Wegovy weight loss treatments.
The group reported a net profit of 26.5 billion kroner, up 32% on last...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE